About the DTU
› Home page
| Trial Evaluating Cardiovascular Outcomes With Sitagliptin | ![]() |
Sites |
|
Clinical SitesApproximately 600 clinical sites will be involved in TECOS, located in the following global locations: Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Czech Republic, Estonia, Finland, France, Germany, Hong Kong, Hungary, India, Israel, Italy, Korea, Latvia, Lithuania, Malaysia, Netherlands, Norway, New Zealand, Poland, Romania, Russia, Singapore, Slovakia, South Africa, Spain, Sweden, Taiwan, Turkey, UK, USA Newly added countries are shown in blue on the map.
|
|